1. MAPK/ERK Pathway Stem Cell/Wnt Apoptosis Immunology/Inflammation NF-κB Metabolic Enzyme/Protease
  2. ERK Apoptosis Bcl-2 Family Caspase Reactive Oxygen Species (ROS)
  3. ERK5-IN-7

ERK5-IN-7 is an orally active ERK5 inhibitor with an IC50 of 403.4 nM. ERK5-IN-7 directly inhibits ERK5 kinase activity, and downregulates the phosphorylation level and total protein expression of ERK5. ERK5-IN-7 induces Apoptosis (upregulates Bax, downregulates Bcl-2, and induces Caspase-3 cleavage). ERK5-IN-7 induces ROS accumulation. ERK5-IN-7 exhibits anticancer effects against Lewis lung cancer.

For research use only. We do not sell to patients.

ERK5-IN-7

ERK5-IN-7 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

ERK5-IN-7 is an orally active ERK5 inhibitor with an IC50 of 403.4 nM. ERK5-IN-7 directly inhibits ERK5 kinase activity, and downregulates the phosphorylation level and total protein expression of ERK5. ERK5-IN-7 induces Apoptosis (upregulates Bax, downregulates Bcl-2, and induces Caspase-3 cleavage). ERK5-IN-7 induces ROS accumulation. ERK5-IN-7 exhibits anticancer effects against Lewis lung cancer[1].

IC50 & Target[1]

ERK5

403.4 nM (IC50)

Bax

 

Bcl-2

 

Caspase-3

 

In Vitro

ERK5-IN-7 (serially diluted concentrations; 10 min pre-incubation at 25 °C, 60 min at 25 °C) potently inhibits purified recombinant human ERK5 kinase activity with an IC50 of 403.4 nM[1].
ERK5-IN-7 (20 μg/mL; 48 h) inhibits A549 human non-small cell lung cancer cell proliferation with an IC50 of 40.1 μM after 48 h of treatment[1].
ERK5-IN-7 (20-80 μM; 48 h) concentration-dependently suppresses phosphorylated and total ERK5 protein expression in A549 cells after 48 h of treatment[1].
ERK5-IN-7 (20-80 μM; 48 h) concentration-dependently induces apoptosis in A549 cells via the intrinsic mitochondrial pathway, including Bax upregulation, Bcl-2 downregulation, and caspase-3 activation, after 48 h of treatment[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[1]

Cell Line: Human non-small cell lung cancer A549 cells
Concentration: 20-80 μM
Incubation Time: 48 h
Result: Increased the apoptotic rate from 7.7% (control) to 79.8%.
Upregulated pro-apoptotic Bax expression.
Downregulated anti-apoptotic Bcl-2 expression.
Induced caspase-3 cleavage.
In Vivo

ERK5-IN-7 (12.5-25 mg/kg; p.o.; for 9 consecutive days) exhibits anticancer activity in a mouse model of Lewis lung cancer[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (male, 20-25 g, subcutaneous inoculation with Lewis lung carcinoma cells)[1]
Dosage: 12.5 mg/kg; 25 mg/kg
Administration: p.o.; 9 consecutive days
Result: Achieved a 30.8% tumor growth inhibition rate at 12.5 mg/kg.
Achieved a 49.3% tumor growth inhibition rate at 25 mg/kg.
Showed no significant changes in mouse body weight throughout the treatment period.
Downregulated ERK5 expression in tumor tissues.
Upregulated the pro-apoptotic protein Bax in tumor tissues.
Downregulated the anti-apoptotic protein Bcl-2 in tumor tissues.
Reduced Ki67-positive cells in tumor tissues.
Caused no observable pathological alterations in major organs (heart, liver, spleen, lungs, kidneys) compared to controls.
Molecular Weight

373.24

Formula

C18H14Cl2N4O

SMILES

O=C(C1=CC=CC(Cl)=C1Cl)N(CC2)CC=C2C3=CNC4=NC=NC=C43

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
ERK5-IN-7
Cat. No.:
HY-181477
Quantity:
MCE Japan Authorized Agent: